Mr. Gaglione has extensive financial leadership experience across public and private biopharma start-ups as well as large pharmaceutical companies. Prior to joining Panavance, Mr. Gaglione was Chief Financial Officer and Vice President of Finance at Matinas Biopharma where he led and executed the Company’s financial strategies. Earlier, he served as Senior Director of Finance at Shionogi USA, Inc., and was responsible for budgeting and financial planning. He also served as Vice President of Finance and Controller for Phytomedics, Inc., a start-up botanical pharmaceutical company and was Controller for ProStrakan Inc.’s U.S. operations. Mr. Gaglione was also Executive Director at Reliant Pharmaceuticals, initially as Head of Planning, Budgets and Analysis, and then as Head of Internal Audit and Sarbanes Oxley Compliance in preparation for a potential initial public offering. Before Reliant, he held numerous finance positions of increasing responsibility at the U.S. subsidiary of Hoffmann-La Roche Inc, including Vice President of R&D Finance, Director of Compensation and Controller for the U.S. pharmaceutical division and sites. He started his finance career at KPMG LLP. Mr. Gaglione earned a B.S. degree in Business Administration with a major in Accounting from Villanova University, and an MBA in Finance from Seton Hall University.